Stock comparison
Align Technology
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ALGN
Align Technology
Market cap
$11.71B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.27B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ALGN | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 56C | 77B | LMAT |
| Benjamin Graham | 66B | 89A | LMAT |
| Philip Fisher | 40D | 81C | LMAT |
| Peter Lynch | 18F | 67B | LMAT |
| Joel Greenblatt | 36D | 56D | LMAT |
| Charlie Munger | 42D | 68D | LMAT |
| Terry Smith | 44D | 69D | LMAT |
Side-by-side metrics
| Metric | ALGN | LMAT |
|---|---|---|
| Market cap | $11.71B | $2.27B |
| P/E (TTM) | 26.1x | 37.1x |
| EV/EBIT | 16.7x | 36.6x |
| ROIC (TTM) | 9.72% | 9.43% |
| Gross margin | 67.68% | 72.39% |
| Net margin | 10.5% | 24.35% |
| Revenue CAGR 5y | 0.52% | 12.75% |
| EPS CAGR 5y | -12.78% | 19.04% |
| Debt / Equity | 0.0x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ALGN leads on
- Debt / Equity0.0xvs 0.5x+96%
- Market cap$11.71Bvs $2.27B+81%
- EV/EBIT16.7xvs 36.6x+54%
- P/E (TTM)26.1xvs 37.1x+30%
LMAT leads on
- EPS CAGR 5y19.04%vs -12.78%+167%
- Dividend yield0.84%vs 0.0%+100%
- Revenue CAGR 5y12.75%vs 0.52%+96%
- Net margin24.35%vs 10.5%+57%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.